The Value of Independent Drug Assessment

The Value of Independent Drug Assessment

THE VALUE OF INDEPENDENT DRUG ASSESSMENT
Issue: BCMJ, vol. 61 , No. 3 , April 2019 , Pages 125-127 Premise

By: James M. Wright, MD, PhD, FRCPC Ken Bassett, MD, PhD Thomas L. Perry Jr., MD Aaron M. Tejani, PharmD

Type 2 diabetes in British Columbia as a case study to explain the work of UBC’s Therapeutics Initiative.

Read more…

No Comments

Post A Comment